Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Main activities include production of breeding bull semen and milk testing services, with genetics sector contributing 78% and milk testing 17.3% of net turnover for the period.
Net turnover for the first six months of 2026 reached €1,019.5 thousand, up 6.6% year-over-year.
Profit before corporate income tax was €124.7 thousand, a 116% increase compared to the same period last year.
No major events or significant risks impacted the financial statement during the reporting period.
Focus remains on expanding product and service volumes through operational efficiency.
Financial highlights
Net sales increased to €1,019,472 from €956,178 year-over-year.
Profit after tax was €116,239, up from €57,671 in the prior year period.
Earnings per share (EPS) rose to €0.275 from €0.137 year-over-year.
Cash and cash equivalents at period end were €50,103, down from €135,487 at the end of 2025.
Dividends of €33,795 were distributed during the period.
Outlook and guidance
Continued emphasis on operational efficiency and expansion of marketed products and services.
Latest events from Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija
- Profit after tax more than doubled year-over-year, with EPS rising to €0.166.SCM1R
Q1 2026 - 2025 net turnover rose 17.3% to €1.94M, but profit fell to €29.1K; dividend payout proposed.SCM1R
Q4 2025 - Net sales, profit, and EPS rose year-over-year, with improved equity and cash flow.SCM1R
Q3 2025 - Net turnover grew 24.5% year-over-year, but profit before tax fell 6% to €57.7k.SCM1R
Q2 2025 - Net sales rose 6% but net profit and EPS declined for the nine months of 2024.SCM1R
Q3 2024 - Net turnover up 1% to €768.3k, but profit before tax down 27.6% to €61.4k.SCM1R
Q2 2024 - 2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.SCM1R
Q4 2024 - Net sales up 24% and net profit increased, but operating cash flow turned negative.SCM1R
Q1 2025